Osaic Holdings
JSPR icon

Osaic Holdings’s Jasper Therapeutics JSPR Stock Holding History

Osaic Holdings’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.8K Hold
40,850
– – ﹤0.01% 5455
2025
Q4 		$74.8K Sell
40,850
-837
-2% -$1.68K ﹤0.01% 4956
2025
Q3 		$99.7K Buy
41,687
+40,850
+4,881% +$124K ﹤0.01% 4785
2025
Q2 		$4.64K Hold
837
– – ﹤0.01% 6582
2025
Q1 		$3.6K Hold
837
– – ﹤0.01% 6349
2024
Q4 		$17.9K Hold
837
– – ﹤0.01% 5421
2024
Q3 		$15.7K Hold
837
– – ﹤0.01% 5520
2024
Q2 		$19K Buy
+837
New +$20.1K ﹤0.01% 5382

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Osaic Holdings's JSPR Position: Q1 2026 in Review

Osaic Holdings held its Jasper Therapeutics (JSPR) position steady in Q1 2026 at 40,850 shares worth $35.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5455.

Osaic Holdings first reported a position in JSPR in Q2 2024 and has held it in 8 quarters since. The position peaked at $99.7K in Q3 2025. 58 funds tracked by Wall St. Rank hold JSPR as of Q1 2026.

  • Osaic Holdings held 40,850 shares of Jasper Therapeutics worth $35.8K as of Q1 2026.
  • Osaic Holdings left its Jasper Therapeutics share count unchanged in Q1 2026.
  • Jasper Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5455 holding.
  • Osaic Holdings first reported a position in Jasper Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Osaic Holdings's Jasper Therapeutics position peaked at $99.7K in Q3 2025.
  • 58 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.